Sentinel brain-protection device during atrial fibrillation ablation
Part of Heart & circulation clinical trials.
This trial tests whether a specialized “brain protection” device can improve safety during atrial fibrillation (AF) catheter ablation. It may help reduce the risk of stroke or related complications while treating AF.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and getting an AF ablation done through a catheter
- Your AF type is paroxysmal, persistent, or long-standing persistent, and your doctor plans ablation by guideline-based reasons
- You can give informed consent and understand the study
- A pre-procedure CT scan shows your blood-vessel and aortic-arch shape and sizes are suitable for the device
- You had a stroke or a “mini-stroke” (TIA) more than 6 months ago (none in the last 6 months)
- You do not have a known left-heart blood clot (left atrial thrombus), and you are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This trial tests whether an early procedure (catheter ablation) for atrial fibrillation (AF) can prevent strokes in people with a high risk of stroke. The goal is to see if this treatment is safer and more effective than standard care for patients with other health conditions.
This trial tests a new pulsed-field device used during an atrial fibrillation (AF) catheter ablation, aiming to improve safety and effectiveness. It’s for people who have AF and are planning an AF ablation procedure.
This trial studies a way to help protect the brain during a catheter procedure that closes the left atrial appendage (a small heart pouch) in people with atrial fibrillation. It may help lower the risk of stroke-related brain injury for patients who can’t safely take blood thinners.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
This trial studies abnormal electrical signals in the right upper heart chamber and how they relate to atrial fibrillation (AF). It may help improve how doctors target AF treatment during catheter ablation for people who have AF symptoms.
Hear when a new Arrhythmia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.